Open an account

aTyr Pharma

ATYR · NASDAQ

$0.1733+$0.00 (+0.00%)TodayMarket closed ·
Prev close $0.1733

Latest news

  • NewsVandana Singh

    Positive FDA Alignment Boosts ATyr Pharma's Rare Lung Disease

  • Press releaseGlobe Newswire

    aTyr Pharma Announces Alignment with FDA on Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis

  • Press releaseGlobe Newswire

    aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis

  • Press releaseGlobe Newswire

    aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD

  • Press releaseGlobe Newswire

    aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Monday's After-Market Session

  • Press releaseGlobe Newswire

    aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting

  • Press releaseGlobe Newswire

    aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • Press releasePRNewswire

    Johnson Fistel Investigates Claims on Behalf of aTyr Pharma, Inc. (ATYR) Shareholders

  • Press releasePRNewswire

    ATYR Deadline: ATYR Investors with Losses Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit

  • Press releaseGlobe Newswire

    Shareholders that lost money on aTyr Pharma, Inc.(ATYR) Urged to Join Class Action – Contact The Gross Law Firm to Learn More

  • Press releaseBusiness Wire

    FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

  • Press releaseGlobe Newswire

    ATYR DEADLINE ALERT: Hagens Berman Alerts aTyr Pharma (ATYR) Investors of Today's Lead Plaintiff Deadline in Securities Class Action

  • Press releasePRNewswire

    ATYR LAWSUIT ALERT: The Gross Law Firm Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

  • Press releasePRNewswire

    aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - ATYR

  • Press releasePRNewswire

    ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm

  • Press releaseGlobe Newswire

    ATYR CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds aTyr Investors to Contact the Firm Before December 8th Regarding Their Rights

  • Press releasePRNewswire

    Investors who lost money on aTyr Pharma, Inc.(ATYR) should contact Levi & Korsinsky about pending Class Action - ATYR

  • Press releasePRNewswire

    aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

  • Press releasePRNewswire

    ATYR 3-DAY DEADLINE ALERT: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure

  • Press releaseGlobe Newswire

    Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Pharma, Inc. Lawsuit – ATYR

  • Press releaseBusiness Wire

    Deadline Soon: aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

  • Press releasePRNewswire

    INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

  • Press releasePRNewswire

    aTyr Pharma, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before December 8, 2025 to Discuss Your Rights - ATYR

  • Press releasePRNewswire

    aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - ATYR

  • Press releasePRNewswire

    ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm

  • Press releaseGlobe Newswire

    The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Lawsuit – ATYR

  • Press releasePRNewswire

    ATYR 5-DAY DEADLINE ALERT: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure

  • Press releasePRNewswire

    ATYR Deadline: ATYR Investors with Losses Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit

  • Press releaseGlobe Newswire

    Deadline Alert: aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

  • Press releasePRNewswire

    Shareholders that lost money on aTyr Pharma, Inc.(ATYR) should contact Levi & Korsinsky about pending Class Action - ATYR

  • Press releasePRNewswire

    ATYR 1-WEEK DEADLINE ALERT: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure

  • Press releaseGlobe Newswire

    Bragar Eagel & Squire, P.C. Urgently Reminds Stockholders of Molina, aTyr, and Marex to Contact the Firm Before Upcoming Deadlines

  • Press releasePRNewswire

    aTyr Pharma (ATYR) Securities Class Action Pending Over Key Drug's Efficacy -- Hagens Berman

  • Press releasePRNewswire

    aTyr Pharma (ATYR) Posts Wider-Than-Expected Loss as Investor Litigation Over Key Drug's Efficacy Moves Forward -- Hagens Berman

  • Press releaseGlobe Newswire

    aTyr Pharma (ATYR) Posts Wider-Than-Expected Loss as Investor Litigation Over Key Drug's Efficacy Moves Forward -- Hagens Berman

  • News

    12 Health Care Stocks Moving In Monday's After-Market Session

  • News

    Benzinga Bulls And Bears: Intel, FedEx, Cracker Barrel — And Markets Close At Record Highs

  • NewsAvi Kapoor

    Goldman Sachs To Rally around 9%? Here Are 10 Top Analyst Forecasts For Tuesday

  • NewsAvi Kapoor

    GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.